Teva- Pharmaceutical Industries Ltd. (TEVA) Stock Forecast & Predictions

Teva- Pharmaceutical Industries Ltd. - ADR TEVA: $9.17

5 Bazel St, P O B 3190, Petah Tikva, Israel. | Sector: Manufacturing | Exchange: NEW YORK STOCK EXCHANGE INC. | Web: http://www.tevapharm.com

  • Market Cap$10.11B
  • Change (52 Weeks)-23.33%
  • Low (52 Weeks)$7.73
  • Teva- Pharmaceutical Industries Ltd. (TEVA) Stock Forecast By Analysts


    On Hold
    Analysts Recommendations for Teva- Pharmaceutical Industries Ltd. (TEVA) is based on 10 Institutional Analyst Ratings where 0.00% are on Strong Buy, 0.00% on Moderate Buy, 40.00% remains on Hold, 20.00% are on Moderate Sell and 40.00% are on Strong Sell.

    Out of 10 Institutional Analysts, majority recommended TEVA stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Teva- Pharmaceutical Industries Ltd..

    Teva- Pharmaceutical Industries Ltd. (TEVA) Stock Price Prediction By Analysts


    HighLowAverage
    $0.03$0.03$0.03
    $0.0399.65% Downside
    Updated: 2022-01-13 00:00:00

    The Average Price target for TEVA set by the institutional analysts is $0.03 where High Estimate is $0.03, Median $0.03232923832923845 and Low $0.03.

    The average price target for TEVA by Institutional Analysts is $0.03, which is 99.65% Downside from the current price. So according to the Institutional Analysts, TEVA Stock might be a bit overvalued at this stage and there’s potential for downside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Teva- Pharmaceutical Industries Ltd. (TEVA) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    OppenheimerPerformInitiated
    BMO CapitalMarket PerformMaintained
    SVB LeerinkMarket PerformMaintained
    BarclaysEqual-WeightUpgraded
    Goldman SachsNeutralInitiated
    SunTrust Robinson HumphreyBuyUpgraded
    UBSBuyMaintained
    Piper SandlerNeutralMaintained
    UBSBuyUpgraded
    Morgan StanleyUnderweightMaintained
    B of A SecuritiesUnderperformMaintained
    Wells FargoEqual-WeightMaintained
    Argus ResearchBuyMaintained
    Morgan StanleyUnderweightMaintained
    SunTrust Robinson HumphreyHoldMaintained
    OppenheimerOutperformMaintained
    B of A SecuritiesUnderperformMaintained
    CFRAHoldMaintained
    Cantor FitzgeraldNeutralMaintained
    Wells FargoEqual-WeightMaintained
    JP MorganNeutralUpgraded
    PiperJaffrayNeutralMaintained
    Gabelli & Co.BuyUpgraded
    Wells FargoMarket PerformMaintained
    GuggenheimNeutralInitiated
    JP MorganUnderweightMaintained
    BMO CapitalMarket PerformMaintained
    Morgan StanleyUnderweightDowngraded
    BarclaysUnderweightInitiated
    OppenheimerOutperformUpgraded
    Bank of AmericaUnderperformDowngraded
    UBSNeutralDowngraded
    Wells FargoMarket PerformMaintained
    CitigroupBuyMaintained
    Wells FargoMarket PerformMaintained
    BMO CapitalMarket PerformInitiated
    SunTrust Robinson HumphreyHoldInitiated
    Morgan StanleyEqual-WeightDowngraded
    Raymond JamesOutperformUpgraded
    Credit SuisseNeutralMaintained
    PiperJaffrayNeutralUpgraded
    Bank of AmericaBuyUpgraded
    Morgan StanleyOverweightUpgraded
    Bank of AmericaUnderperformMaintained
    Leerink SwannMarket PerformUpgraded
    Goldman SachsBuyMaintained
    MizuhoBuyMaintained
    Credit SuisseNeutralMaintained
    BTIG ResearchNeutralUpgraded
    Credit SuisseNeutralDowngraded
    BarclaysEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    Cantor FitzgeraldNeutralMaintained
    Wells FargoMarket PerformUpgraded
    CitigroupBuyMaintained
    BarclaysEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    Credit SuisseOutperformMaintained
    PiperJaffrayUnderweightDowngraded
    Leerink SwannUnderperformMaintained
    Deutsche BankHoldMaintained
    Bank of AmericaUnderperformMaintained
    BTIG ResearchNeutralDowngraded
    MizuhoBuyUpgraded
    Wells FargoUnderperformDowngraded
    CitigroupBuyUpgraded
    Leerink SwannUnderweightInitiated
    Morgan StanleyEqual-WeightUpgraded
    Goldman SachsBuyUpgraded
    Credit SuisseNeutralUpgraded
    GuggenheimNeutralInitiated
    JP MorganUnderweightDowngraded
    CitigroupNeutralMaintained
    Credit SuisseUnderperformMaintained
    Morgan StanleyUnderweightMaintained
    Deutsche BankHoldDowngraded
    BarclaysEqual-WeightMaintained
    Morgan StanleyUnderweightMaintained
    BarclaysEqual-WeightMaintained
    BTIG ResearchBuyUpgraded
    JMP SecuritiesUnderperformMaintained
    Credit SuisseUnderperformDowngraded
    CitigroupNeutralDowngraded
    Morgan StanleyUnderweightDowngraded
    BarclaysEqual-WeightMaintained
    RBC CapitalUnderperformDowngraded
    Credit SuisseNeutralDowngraded
    Cowen & Co.Market PerformDowngraded
    BernsteinMarket PerformDowngraded
    OppenheimerPerformDowngraded
    MizuhoNeutralUpgraded
    MizuhoNeutralUpgraded
    Cantor FitzgeraldNeutralInitiated
    ArgusHoldDowngraded
    MizuhoUnderperformDowngraded
    Bank of AmericaBuyUpgraded
    JP MorganNeutralDowngraded
    Morgan StanleyEqual-WeightDowngraded
    JefferiesHoldDowngraded
    BTIG ResearchNeutralDowngraded
    BarclaysEqual-WeightInitiated
    Bank of AmericaNeutralDowngraded
    HSBCHoldDowngraded
    Credit SuisseOutperformUpgraded
    MizuhoNeutralDowngraded
    OTR GlobalPositiveInitiated
    OppenheimerOutperformUpgraded
    Leerink SwannOutperformMaintained
    BTIG ResearchBuyMaintained
    HSBCBuyUpgraded
    OppenheimerOutperformMaintained
    JefferiesBuyMaintained
    Credit SuisseNeutralInitiated
    Morgan StanleyOverweightMaintained
    Wells FargoOutperformInitiated
    Deutsche BankBuyMaintained
    Deutsche BankBuyMaintained
    MizuhoBuyInitiated
    GuggenheimBuyUpgraded
    Goldman SachsBuyUpgraded
    NomuraNeutralInitiated
    JP MorganOverweightUpgraded
    Leerink SwannOutperformMaintained
    BMO CapitalOutperformUpgraded
    Standpoint ResearchBuyMaintained
    BTIG ResearchBuyInitiated
    Raymond JamesMarket PerformInitiated
    Standpoint ResearchBuyUpgraded
    Argus ResearchBuyMaintained
    ArgusBuyMaintained
    BMO CapitalMarket PerformDowngraded
    Deutsche BankBuyMaintained
    BarclaysOverweightMaintained
    Standpoint ResearchHoldDowngraded
    Leerink SwannOutperformMaintained
    OppenheimerOutperformUpgraded
    CRT CapitalBuyMaintained
    Canaccord GenuityHoldMaintained
    JP MorganNeutralMaintained
    Leerink SwannOutperformMaintained
    JefferiesBuyMaintained
    Sterne AgeeBuyUpgraded
    Deutsche BankBuyMaintained
    Bank of AmericaBuyMaintained
    Canaccord GenuityHoldMaintained
    RBC CapitalOutperformUpgraded
    Morgan StanleyEqual-WeightMaintained
    StandpointBuyUpgraded
    StandpointHoldDowngraded
    UBSNeutralMaintained
    JP MorganNeutralMaintained
    BarclaysOverweightMaintained
    Wells FargoMarket PerformInitiated
    JP MorganNeutralMaintained
    Argus ResearchBuyUpgraded
    ArgusBuyUpgraded
    Sterne AgeeNeutralInitiated
    National AllianceBuyInitiated
    JP MorganNeutralMaintained
    CitigroupBuyMaintained
    UBSNeutralMaintained
    CitigroupBuyMaintained
    Goldman SachsNeutralUpgraded
    Morgan StanleyEqual-weightUpgraded
    JP MorganNeutralUpgraded
    BarclaysOverweightUpgraded
    Leerink SwannOutperformUpgraded
    CitigroupBuyMaintained
    CitigroupBuyMaintained
    RBC CapitalSector PerformInitiated
    SusquehannaPositiveUpgraded
    JP MorganUnderweightDowngraded
    BMO CapitalOutperformMaintained
    BarclaysMarket WeightDowngraded
    CitigroupBuyInitiated
    JP MorganNeutralDowngraded
    Morgan StanleyUnderweightDowngraded
    Morgan StanleyEqual-WeightMaintained
    Goldman SachsSellDowngraded
    Maxim GroupBuyInitiated
    BMO CapitalOutperformInitiated
    Wells FargoMarket PerformDowngraded
    Argus ResearchHoldDowngraded
    ArgusHoldDowngraded
    Bank of AmericaBuyMaintained
    Leerink SwannMarket PerformDowngraded
    UBSNeutralDowngraded
    Buckingham ResearchNeutralDowngraded
    Canaccord GenuityBuyMaintained
    Goldman SachsNeutralMaintained
    Morgan StanleyEqual-WeightMaintained
    UBSBuyMaintained
    CitigroupBuyMaintained
    Bank of AmericaBuyMaintained
    NeedhamHoldDowngraded
    Clal FinanceMarket PerformMaintained

    Teva- Pharmaceutical Industries Ltd. (TEVA) Stock Earning Per Share (EPS) Forecast / Estimate


    $0.734
    The average consensus EPS for TEVA is $0.734 with a high estimate of $0.756 and Low of $0.706 for the period 2021-12-31 and based on 3 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $0.59$0.64262021-06-30


    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $0.59$0.65282021-09-30
    $0.59$0.64262021-06-30
    $0.63$0.62222021-03-31
    $0.68$0.64262020-12-31
    $0.58$0.60182020-09-30
    $$2020-06-30
    $0.93$2017-12-31
    $1$1.08122017-09-30
    $1.02$1.1222017-06-30
    $$2017-03-31
    $1.38$1.3772016-12-31
    $$2016-06-30
    $$2016-03-31
    $$2015-12-31
    $1.35$1.28862015-09-30
    $1.43$1.36342015-06-30
    $$2015-03-31
    $1.31$1.3262014-12-31
    $1.32$1.23012014-09-30
    $1.23$1.22782014-06-30
    $1.22$1.19852014-03-31
    $1.42$1.4792013-12-31
    $1.27$1.3092013-09-30
    $1.2$1.23422013-06-30
    $1.12$1.2412013-03-31
    $1.32$1.36682012-12-31
    $1.28$1.31332012-09-30
    $1.28$1.36172012-06-30
    $1.47$1.44842012-03-31
    $$2011-12-31
    $$2011-09-30
    $$2011-06-30
    $0.91$0.93842010-03-31
    $0.94$0.96392009-12-31
    $0.89$0.88232009-09-30
    $0.61$0.79562009-06-30
    $0.51$0.68852009-03-31
    $0.80455$0.71552008-12-31
    $0.8054399999999999$0.72422008-09-30
    $0.67876$2008-06-30

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).